Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucose Transporter Type 4 | 26 | 2021 | 62 | 5.850 |
Why?
|
| Adipocytes | 12 | 2024 | 56 | 3.970 |
Why?
|
| Glucose | 8 | 2024 | 204 | 3.290 |
Why?
|
| Adipose Tissue | 7 | 2024 | 183 | 2.180 |
Why?
|
| Insulin | 12 | 2021 | 315 | 1.850 |
Why?
|
| Phosphofructokinase-2 | 2 | 2024 | 11 | 1.660 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 632 | 1.500 |
Why?
|
| Insulin Resistance | 5 | 2024 | 173 | 1.470 |
Why?
|
| Monosaccharide Transport Proteins | 8 | 2020 | 23 | 1.320 |
Why?
|
| Muscle Proteins | 7 | 2005 | 56 | 1.280 |
Why?
|
| 3T3-L1 Cells | 6 | 2021 | 29 | 1.170 |
Why?
|
| Mice | 24 | 2024 | 4621 | 1.100 |
Why?
|
| Promoter Regions, Genetic | 11 | 2017 | 343 | 1.100 |
Why?
|
| Histone Deacetylases | 3 | 2012 | 26 | 1.010 |
Why?
|
| Animals | 29 | 2024 | 10370 | 0.960 |
Why?
|
| Signal Transduction | 8 | 2018 | 1433 | 0.920 |
Why?
|
| Homeostasis | 1 | 2024 | 117 | 0.870 |
Why?
|
| Obesity | 3 | 2019 | 667 | 0.850 |
Why?
|
| Muscle, Skeletal | 6 | 2016 | 633 | 0.820 |
Why?
|
| Mice, Knockout | 1 | 2024 | 836 | 0.760 |
Why?
|
| Myogenic Regulatory Factors | 6 | 2009 | 20 | 0.750 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 57 | 0.640 |
Why?
|
| Genes, Reporter | 3 | 2018 | 87 | 0.640 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 66 | 0.640 |
Why?
|
| Microtubules | 3 | 2006 | 90 | 0.630 |
Why?
|
| Weight Loss | 1 | 2019 | 80 | 0.620 |
Why?
|
| Gene Expression | 2 | 2018 | 415 | 0.600 |
Why?
|
| Cytoskeleton | 3 | 2009 | 44 | 0.590 |
Why?
|
| Adipocytes, White | 1 | 2017 | 10 | 0.570 |
Why?
|
| Physical Conditioning, Animal | 2 | 2016 | 38 | 0.560 |
Why?
|
| Molecular Imaging | 1 | 2018 | 35 | 0.560 |
Why?
|
| NADP | 1 | 2017 | 38 | 0.560 |
Why?
|
| Adipogenesis | 1 | 2017 | 26 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 1561 | 0.540 |
Why?
|
| NAD | 1 | 2017 | 100 | 0.530 |
Why?
|
| Triglycerides | 2 | 2016 | 121 | 0.530 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2013 | 7 | 0.530 |
Why?
|
| Amino Acids | 1 | 2016 | 82 | 0.510 |
Why?
|
| Diet, High-Fat | 2 | 2016 | 135 | 0.500 |
Why?
|
| DNA-Binding Proteins | 5 | 2009 | 490 | 0.500 |
Why?
|
| Mice, Transgenic | 9 | 2016 | 507 | 0.500 |
Why?
|
| Transcription Factors | 5 | 2009 | 520 | 0.490 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 16 | 0.450 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2014 | 30 | 0.450 |
Why?
|
| Cell Differentiation | 2 | 2021 | 406 | 0.440 |
Why?
|
| Endosomes | 1 | 2014 | 45 | 0.440 |
Why?
|
| Actins | 2 | 2005 | 95 | 0.440 |
Why?
|
| PPAR alpha | 1 | 2013 | 33 | 0.420 |
Why?
|
| Mitochondria | 1 | 2016 | 369 | 0.420 |
Why?
|
| Biological Transport | 5 | 2020 | 121 | 0.410 |
Why?
|
| Glycolysis | 2 | 2024 | 85 | 0.400 |
Why?
|
| Cyclic AMP | 1 | 2012 | 86 | 0.370 |
Why?
|
| Fasting | 1 | 2012 | 81 | 0.370 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 2010 | 8 | 0.370 |
Why?
|
| Down-Regulation | 3 | 2012 | 199 | 0.370 |
Why?
|
| Liver X Receptors | 3 | 2017 | 22 | 0.350 |
Why?
|
| Male | 8 | 2024 | 13424 | 0.330 |
Why?
|
| Adiponectin | 2 | 2021 | 29 | 0.320 |
Why?
|
| Protein Transport | 3 | 2018 | 157 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 155 | 0.300 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 128 | 0.290 |
Why?
|
| Cell Line | 2 | 2021 | 695 | 0.280 |
Why?
|
| Humans | 16 | 2023 | 27968 | 0.280 |
Why?
|
| Transcription, Genetic | 4 | 2012 | 403 | 0.270 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 86 | 0.260 |
Why?
|
| Cells, Cultured | 3 | 2017 | 984 | 0.250 |
Why?
|
| Phosphorylation | 5 | 2013 | 574 | 0.250 |
Why?
|
| Cell Membrane | 2 | 2006 | 257 | 0.240 |
Why?
|
| MEF2 Transcription Factors | 5 | 2008 | 12 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 94 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 140 | 0.220 |
Why?
|
| Tubulin | 1 | 2003 | 31 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2016 | 510 | 0.210 |
Why?
|
| 3T3 Cells | 4 | 2005 | 46 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 135 | 0.200 |
Why?
|
| Polymers | 1 | 2003 | 117 | 0.200 |
Why?
|
| COS Cells | 3 | 2008 | 49 | 0.190 |
Why?
|
| Dementia | 1 | 2023 | 90 | 0.190 |
Why?
|
| Liver | 2 | 2016 | 433 | 0.190 |
Why?
|
| Xanthines | 1 | 2021 | 3 | 0.190 |
Why?
|
| Apelin | 1 | 2021 | 5 | 0.180 |
Why?
|
| Apelin Receptors | 1 | 2021 | 11 | 0.180 |
Why?
|
| Dexamethasone | 1 | 2021 | 63 | 0.180 |
Why?
|
| Peritoneal Neoplasms | 1 | 2021 | 79 | 0.170 |
Why?
|
| Protein Binding | 3 | 2008 | 657 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 263 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2003 | 483 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2010 | 136 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 461 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 404 | 0.150 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 16 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2017 | 29 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2017 | 34 | 0.140 |
Why?
|
| Stromal Cells | 1 | 2017 | 60 | 0.140 |
Why?
|
| Aging | 1 | 2024 | 968 | 0.140 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2016 | 10 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2017 | 78 | 0.130 |
Why?
|
| Glycogen | 1 | 2016 | 23 | 0.130 |
Why?
|
| Naphthyridines | 1 | 2016 | 4 | 0.130 |
Why?
|
| Mice, Obese | 1 | 2016 | 21 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 20 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 329 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2017 | 246 | 0.130 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 59 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 82 | 0.120 |
Why?
|
| Sirolimus | 1 | 2016 | 76 | 0.120 |
Why?
|
| Rats | 2 | 2018 | 1570 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 93 | 0.120 |
Why?
|
| Nocodazole | 2 | 2006 | 11 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 588 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2016 | 309 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2010 | 657 | 0.110 |
Why?
|
| Thiazolidines | 2 | 2005 | 6 | 0.110 |
Why?
|
| Receptors, Transferrin | 1 | 2014 | 18 | 0.110 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2005 | 52 | 0.110 |
Why?
|
| Biomarkers | 1 | 2017 | 756 | 0.110 |
Why?
|
| Thiazoles | 2 | 2005 | 51 | 0.110 |
Why?
|
| Fatty Acid Synthases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 17 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 25 | 0.100 |
Why?
|
| Eating | 1 | 2013 | 70 | 0.100 |
Why?
|
| Epoxy Compounds | 1 | 2010 | 4 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 134 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 12 | 0.080 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 23 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 82 | 0.080 |
Why?
|
| Mitochondria, Muscle | 1 | 2010 | 43 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 146 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 198 | 0.080 |
Why?
|
| Ifosfamide | 1 | 2009 | 9 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 106 | 0.080 |
Why?
|
| Mitomycin | 1 | 2009 | 19 | 0.080 |
Why?
|
| Dimerization | 1 | 2008 | 76 | 0.070 |
Why?
|
| Cisplatin | 1 | 2009 | 179 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 119 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2007 | 2 | 0.070 |
Why?
|
| DNA | 2 | 2005 | 371 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2006 | 62 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2005 | 267 | 0.070 |
Why?
|
| Aorta | 1 | 2007 | 124 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 163 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2007 | 354 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 29 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 407 | 0.060 |
Why?
|
| Hypertension | 1 | 2007 | 308 | 0.060 |
Why?
|
| MADS Domain Proteins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 47 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 46 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 25 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 32 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 101 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 112 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 136 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 54 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 87 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 284 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 26 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 97 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2003 | 18 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 317 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 233 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 414 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 243 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 186 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 461 | 0.050 |
Why?
|
| Disease Progression | 1 | 2023 | 472 | 0.050 |
Why?
|
| Exercise | 1 | 2005 | 478 | 0.050 |
Why?
|
| Exocytosis | 1 | 2001 | 13 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 188 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 97 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 679 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 315 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2021 | 161 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 330 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 268 | 0.040 |
Why?
|
| Lipids | 1 | 2021 | 207 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1244 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1590 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 802 | 0.040 |
Why?
|
| Brain | 1 | 2023 | 739 | 0.040 |
Why?
|
| Apoptosis | 1 | 2021 | 772 | 0.040 |
Why?
|
| Aged | 1 | 2023 | 5383 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 3 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 352 | 0.020 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2007 | 4 | 0.020 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2005 | 7 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 2005 | 7 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 43 | 0.010 |
Why?
|
| Female | 1 | 2021 | 15074 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 412 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 148 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 544 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 7703 | 0.010 |
Why?
|